术后恶心呕吐的防治研究进展  

Study Progress about Prevention and Therapy of Postoperative Nausea and Vomiting

作　　者：周颖[1] 胡西会[1] 李振英[1] 

机构地区：[1]宝鸡市妇幼保健院麻醉科,陕西宝鸡721000

出　　处：《医学综述》2009年第17期2603-2605,共3页Medical Recapitulate

基　　金：宝鸡市卫生局项目(2008015)

摘　　要：术后恶心呕吐(PONV)是手术后的常见并发症,其发生机制可能和位于脑干的呕吐中枢接受体内一些催吐信号的刺激有关。影响PONV发生的因素包括:性别、吸烟、既往术后恶心和呕吐史、晕动病史、麻醉持续时间、手术类型等。5-羟色胺3受体拮抗剂目前是术后抗吐的最佳药物,对有高危因素的患者,宜采用联合用药及综合防治措施,以降低PONV的发生率。Postoperative nausea and vomiting （PONV）is a common complication in operational patients. PONV may be caused by the stimulating of vomiting center in the brain. Factors affecting the occurrence of PONV include gender, smoking, previous history of PONV, motion history, surgery type, etc. 5- HT3 receptor antagonist is the best anti-vomiting drugs at present. For the patients with risk factors,combination and integrated measures are the effective ways to reduce the incidence of PONV.

关 键 词：术后恶心呕吐 预防 治疗 

分 类 号：R614[医药卫生—麻醉学]